NCT00182533View on ClinicalTrials.gov

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

PHASE4TerminatedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Phobia, SocialPanic DisorderAgoraphobiaObsessive-Compulsive DisorderAnxiety DisordersMajor Depressive Disorder

Interventions

DRUG

Sertraline

25 - 200 mg/day x 16 weeks

DRUG

Placebo

25 - 200 mg/day x 16 weeks

Trial Locations (1)

L8S 1B7

MacAnxiety Research Centre, Hamilton

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Hamilton Health Sciences Corporation

OTHER